Rong (Fiona) Huang
Lawyers
Filters
Flex $500 million notes offering
The investment-grade notes are due 2032
AssetMark strategic alliance with Morningstar and related acquisition of assets
We are advising AssetMark on the strategic alliance and acquisition of assets from Morningstar’s TAMP business
AssetMark $2.7 billion acquisition by GTCR
We are advising AssetMark on the transaction
Gilead Sciences $4.3 billion acquisition of CymaBay Therapeutics
We are advising Gilead Sciences on the acquisition
Intuit $4 billion notes offering
The investment-grade offering comprises four tranches of notes
Vishay Intertechnology $750 million convertible senior notes offering
The 2.25% convertible notes are due 2030
AN2 Therapeutics $70 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Recursion Pharmaceuticals $300 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Upgrade $100 million acquisition of Uplift
We advised Upgrade on the transaction
IDEAYA Biosciences $201 million equity offering
The common stock is listed on the Nasdaq Global Select Market